Pharmadrug Inc.
PHRX
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.40K | 23.60K | -14.60K | 23.20K | 15.30K |
| Depreciation & Amortization | 9.10K | 8.80K | 9.00K | 9.20K | 9.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.50K | 32.40K | 64.20K | 37.10K | 1.70K |
| Operating Income | -14.50K | -32.40K | -64.20K | -37.10K | -1.70K |
| Income Before Tax | -61.30K | -81.60K | -5.00K | -132.70K | -105.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.30K | -81.60K | -5.00K | -132.70K | -105.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.80K | 11.80K | 57.10K | -- | 9.50K |
| Net Income | -52.50K | -69.80K | 52.00K | -132.70K | -95.80K |
| EBIT | -14.50K | -32.40K | -64.20K | -37.10K | -1.70K |
| EBITDA | -5.40K | -23.60K | -55.20K | -27.90K | 7.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 108.23M | 107.77M | 103.30M | 104.14M | 100.39M |
| Average Diluted Shares Outstanding | 108.23M | 107.77M | 103.30M | 104.14M | 100.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |